[Vitamin E and serum lipids in chronic renal insufficiency]. 1977

M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.

Related Publications

M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
November 1981, Vnitrni lekarstvi,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
September 1978, The American journal of clinical nutrition,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
January 1989, Nephron,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
June 1989, Minerva pediatrica,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
January 1969, Clinica chimica acta; international journal of clinical chemistry,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
November 1983, The International journal of artificial organs,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
January 1984, Voprosy meditsinskoi khimii,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
September 1968, Wiener klinische Wochenschrift,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
October 1976, Mayo Clinic proceedings,
M Mydlík, and K Derzsiová, and I Ahlers, and M Takác, and J Jarcuska, and I Kochan
January 2006, Przeglad lekarski,
Copied contents to your clipboard!